A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention

一种新型无线可摄入传感器系统,用于测量艾滋病毒治疗和预防中的药物依从性

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Advances in the last decade have transformed HIV-1 infection into a chronic disease through the use of highly active antiretroviral (ARV) therapy. Recent studies suggest the ARVs used as pre-exposure prophylaxis (PrEP) to prevent HIV infection have the potential to transform the HIV pandemic. However, the success of ARVs in both the treatment and prevention of HIV is critically dependent on taking medications exactly as prescribed (adherence). To date, no reliable, accurate measurement for ARV adherence exists. This proposal will evaluate the use of a novel sensor platform termed the Digital Health Feedback System (DHFS) for real- time adherence monitoring in HIV-infected persons starting ARVs and in persons at high risk for HIV infection starting PrEP. Aim 1: Develop selected digitized ARVs for use within the DHFS. We will combine an edible sensor with commonly used ARVs within a gelcap to allow the DHFS to detect when a person takes their medication. Outcomes will include successful development of a `digitized' panel of ARVs to use with the DHFS, which are tested against USP guidelines and safe for use in clinical settings. Aim 2: Evaluate the use, acceptability, validity, and utility of the DHFS for longitudinal monitoring of adherence during initial ARV therapy. We will assess if the DHFS is acceptable to persons living with HIV that are initiating ARV treatment for the first time. Outcomes include acceptabilit as measured through validated questionnaires and persistence of use by participants, positive detection accuracy of the DHFS as measured by directly observed ingestions at study visits, and medication adherence as measured by DHFS. Aim 3: Evaluate the acceptability, validity, and utility of the DHFS for longitudinal monitoring of ARVs used in HIV pre-exposure prophylaxis (PrEP). We will assess if the DHFS is acceptable to persons at high risk for HIV infection that are initiating PrEP. Outcomes include acceptability as measured through validated questionnaires and persistence of use by participants, positive detection accuracy of the DHFS as measured by directly observed ingestions at study visits, and medication adherence as measured by DHFS.
 描述(由申请人提供):在过去十年中,通过使用高效抗逆转录病毒(ARV)治疗,HIV-1感染已转变为一种慢性疾病。最近的研究表明,用作预防艾滋病毒感染的暴露前预防(PrEP)的ARV有可能改变艾滋病毒的流行。然而,抗逆转录病毒药物在治疗和预防艾滋病毒方面的成功关键取决于严格按照处方服药(坚持)。迄今为止,还没有可靠、准确的抗逆转录病毒药物依从性衡量标准。该提案将评估使用一种新的传感器平台,称为数字健康反馈系统(DHFS)的真实的时间坚持监测艾滋病毒感染者开始抗逆转录病毒药物和艾滋病毒感染的高危人群开始PrEP. Aim 1:开发选定的数字化抗逆转录病毒药物用于DHFS。 我们将联合收割机与常用的抗逆转录病毒药物结合在一起,使DHFS能够检测到一个人何时服用药物。成果将包括成功开发一个“数字化”的抗逆转录病毒药物组,与DHFS一起使用,这些药物根据USP指南进行了测试,在临床环境中使用安全。 目的2:评价DHFS在初始抗逆转录病毒治疗依从性纵向监测中的使用、可接受性、有效性和实用性。 我们将评估首次开始抗逆转录病毒治疗的艾滋病毒感染者是否可以接受DHFS。结果包括可接受性(通过验证的问卷和参与者的持续使用来测量)、DHFS的阳性检测准确性(通过在研究访视时直接观察到的摄入量来测量)和药物依从性(通过DHFS来测量)。 目的3:评价DHFS用于HIV暴露前预防(PrEP)中使用的ARV纵向监测的可接受性、有效性和实用性。 我们将评估DHFS是否可接受的人在艾滋病毒感染的高风险,正在启动PrEP。结果包括可接受性,通过有效的问卷调查和持续使用的参与者,积极的检测准确性DHFS测量直接观察到的摄入量在研究访视,和药物依从性DHFS测量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CONSTANCE ANN BENSON其他文献

CONSTANCE ANN BENSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CONSTANCE ANN BENSON', 18)}}的其他基金

Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients
SARS-CoV-2 的汇总和常规核酸检测策略,用于筛选直接护理研究人员并保护 HIV 患者
  • 批准号:
    10166377
  • 财政年份:
    2020
  • 资助金额:
    $ 100万
  • 项目类别:
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
一种新型无线可摄入传感器系统,用于测量艾滋病毒治疗和预防中的药物依从性
  • 批准号:
    9319811
  • 财政年份:
    2015
  • 资助金额:
    $ 100万
  • 项目类别:
A Novel Wireless Ingestible Sensor System for Measurement of medication Adherence in HIV Treatment and Prevention
一种新型无线可摄入传感器系统,用于测量艾滋病毒治疗和预防中的药物依从性
  • 批准号:
    9411660
  • 财政年份:
    2015
  • 资助金额:
    $ 100万
  • 项目类别:
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
一种新型无线可摄入传感器系统,用于测量艾滋病毒治疗和预防中的药物依从性
  • 批准号:
    9751389
  • 财政年份:
    2015
  • 资助金额:
    $ 100万
  • 项目类别:
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
一种新型无线可摄入传感器系统,用于测量艾滋病毒治疗和预防中的药物依从性
  • 批准号:
    9145781
  • 财政年份:
    2015
  • 资助金额:
    $ 100万
  • 项目类别:
CLINICAL TRIAL: ADULT AIDS CLINICAL TRIALS GROUP LONGITUDINAL LINKED RANDOMIZED
临床试验:成人艾滋病临床试验组纵向连锁随机
  • 批准号:
    8166818
  • 财政年份:
    2009
  • 资助金额:
    $ 100万
  • 项目类别:
AIDS Clinical Trials Group Network
艾滋病临床试验小组网络
  • 批准号:
    7923515
  • 财政年份:
    2009
  • 资助金额:
    $ 100万
  • 项目类别:
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
加州大学圣地亚哥分校医学系艾滋病毒/艾滋病临床试验组
  • 批准号:
    7994193
  • 财政年份:
    2007
  • 资助金额:
    $ 100万
  • 项目类别:
The UCSD CD4 Collaborative Clinical Trial Unit
UCSD CD4 合作临床试验单位
  • 批准号:
    9179576
  • 财政年份:
    2007
  • 资助金额:
    $ 100万
  • 项目类别:
UCSD Collaborative Clinical Trials Unit
加州大学圣地亚哥分校合作临床试验单位
  • 批准号:
    10304895
  • 财政年份:
    2007
  • 资助金额:
    $ 100万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 100万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了